Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review

Toxic epidermal necrolysis (TEN) is a rare and life-threatening severe cutaneous adverse reaction. The conventional treatment approach includes immunomodulatory therapies, such as systemic corticosteroids, cyclosporine, intravenous immunoglobulin (IVIG), and tumor necrosis factor-alpha (TNF-α) inhib...

Full description

Saved in:
Bibliographic Details
Main Authors: Shun-Qi Liao, Zhang-Rong Yan, Lun-Wei Lin, Ming Deng, Guo-Jin Xiao, Pei-Yang Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1579349/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849763152112123904
author Shun-Qi Liao
Zhang-Rong Yan
Lun-Wei Lin
Ming Deng
Guo-Jin Xiao
Pei-Yang Gao
author_facet Shun-Qi Liao
Zhang-Rong Yan
Lun-Wei Lin
Ming Deng
Guo-Jin Xiao
Pei-Yang Gao
author_sort Shun-Qi Liao
collection DOAJ
description Toxic epidermal necrolysis (TEN) is a rare and life-threatening severe cutaneous adverse reaction. The conventional treatment approach includes immunomodulatory therapies, such as systemic corticosteroids, cyclosporine, intravenous immunoglobulin (IVIG), and tumor necrosis factor-alpha (TNF-α) inhibitors. Plasmapheresis, as a potential treatment for TEN, is rarely used in patients with refractory TEN. We report a successful case of plasmapheresis treatment in a patient with refractory TEN who did not respond to conventional treatment, and we provide a literature review. A 65-year-old female presented with diffuse erythematous papules covering her entire body, along with multiple blisters and bullae, and partial detachment of the epidermis and mucosa. The area of epidermal exfoliation exceeded 30% of the total body surface area, and Nikolsky’s sign was positive. Despite a week of methylprednisolone treatment, numerous blisters and bullae developed, and the area of epidermal exfoliation expanded to 62%. IVIG and TNF-α inhibitors were subsequently added, but the disease remained uncontrolled. Plasmapheresis treatment was initiated. Epithelial regeneration was observed after three days of plasmapheresis. After plasmapheresis was given 5 times, the patient finally recovered. This case highlights the significance of plasmapheresis in the treatment of refractory TEN, particularly when conventional therapies are ineffective. More studies are needed in the future to confirm the efficacy of plasmapheresis treatment.
format Article
id doaj-art-ecc3dc98c6494a83a0679dd501af16b7
institution DOAJ
issn 1664-3224
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-ecc3dc98c6494a83a0679dd501af16b72025-08-20T03:05:30ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-05-011610.3389/fimmu.2025.15793491579349Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature reviewShun-Qi Liao0Zhang-Rong Yan1Lun-Wei Lin2Ming Deng3Guo-Jin Xiao4Pei-Yang Gao5Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaNursing Department, Luzhou Hospital of Traditional Chinese Medicine, Luzhou, ChinaDepartment of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaToxic epidermal necrolysis (TEN) is a rare and life-threatening severe cutaneous adverse reaction. The conventional treatment approach includes immunomodulatory therapies, such as systemic corticosteroids, cyclosporine, intravenous immunoglobulin (IVIG), and tumor necrosis factor-alpha (TNF-α) inhibitors. Plasmapheresis, as a potential treatment for TEN, is rarely used in patients with refractory TEN. We report a successful case of plasmapheresis treatment in a patient with refractory TEN who did not respond to conventional treatment, and we provide a literature review. A 65-year-old female presented with diffuse erythematous papules covering her entire body, along with multiple blisters and bullae, and partial detachment of the epidermis and mucosa. The area of epidermal exfoliation exceeded 30% of the total body surface area, and Nikolsky’s sign was positive. Despite a week of methylprednisolone treatment, numerous blisters and bullae developed, and the area of epidermal exfoliation expanded to 62%. IVIG and TNF-α inhibitors were subsequently added, but the disease remained uncontrolled. Plasmapheresis treatment was initiated. Epithelial regeneration was observed after three days of plasmapheresis. After plasmapheresis was given 5 times, the patient finally recovered. This case highlights the significance of plasmapheresis in the treatment of refractory TEN, particularly when conventional therapies are ineffective. More studies are needed in the future to confirm the efficacy of plasmapheresis treatment.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1579349/fulltoxic epidermal necrolysisSteven Johnson syndromeplasmapheresissevere cutaneous adverse reactionrefractory
spellingShingle Shun-Qi Liao
Zhang-Rong Yan
Lun-Wei Lin
Ming Deng
Guo-Jin Xiao
Pei-Yang Gao
Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review
Frontiers in Immunology
toxic epidermal necrolysis
Steven Johnson syndrome
plasmapheresis
severe cutaneous adverse reaction
refractory
title Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review
title_full Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review
title_fullStr Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review
title_full_unstemmed Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review
title_short Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review
title_sort plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy a case report and literature review
topic toxic epidermal necrolysis
Steven Johnson syndrome
plasmapheresis
severe cutaneous adverse reaction
refractory
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1579349/full
work_keys_str_mv AT shunqiliao plasmapheresisforrefractorytoxicepidermalnecrolysisunresponsivetoconventionaltherapyacasereportandliteraturereview
AT zhangrongyan plasmapheresisforrefractorytoxicepidermalnecrolysisunresponsivetoconventionaltherapyacasereportandliteraturereview
AT lunweilin plasmapheresisforrefractorytoxicepidermalnecrolysisunresponsivetoconventionaltherapyacasereportandliteraturereview
AT mingdeng plasmapheresisforrefractorytoxicepidermalnecrolysisunresponsivetoconventionaltherapyacasereportandliteraturereview
AT guojinxiao plasmapheresisforrefractorytoxicepidermalnecrolysisunresponsivetoconventionaltherapyacasereportandliteraturereview
AT peiyanggao plasmapheresisforrefractorytoxicepidermalnecrolysisunresponsivetoconventionaltherapyacasereportandliteraturereview